Insider Transactions in Q1 2022 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Michael J Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,859
+1.3%
|
-
|
|
Mar 31
2022
|
Raymond Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,859
+25.96%
|
-
|
|
Mar 31
2022
|
Christopher M Starr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,859
+28.56%
|
-
|
|
Mar 31
2022
|
Arthur J Klausner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,859
+19.04%
|
-
|
|
Mar 31
2022
|
Kim R Tsuchimoto Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
500
-8.15%
|
$1,000
$2.55 P/Share
|
|
Mar 31
2022
|
Kim R Tsuchimoto Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,221
+16.6%
|
-
|
|
Mar 31
2022
|
Andrew Paul Mazar Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
471
-2.08%
|
$942
$2.55 P/Share
|
|
Mar 31
2022
|
Andrew Paul Mazar Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,606
+6.64%
|
-
|
|
Mar 31
2022
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,155
-3.07%
|
$2,310
$2.55 P/Share
|
|
Mar 31
2022
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,941
+9.47%
|
-
|
|
Jan 01
2022
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,327
-6.45%
|
$6,981
$3.21 P/Share
|
|
Jan 01
2022
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,724
+15.72%
|
-
|
|
Jan 01
2022
|
Kim R Tsuchimoto Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
505
-9.32%
|
$1,515
$3.21 P/Share
|
|
Jan 01
2022
|
Kim R Tsuchimoto Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,231
+18.51%
|
-
|
|
Jan 01
2022
|
Andrew Paul Mazar Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
671
-3.1%
|
$2,013
$3.21 P/Share
|
|
Jan 01
2022
|
Andrew Paul Mazar Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,937
+8.21%
|
-
|